Community pharmacists’ evolving role in Canadian primary health care: a vision of harmonization in a patchwork system

Main Article Content

Keywords

Pharmacies, Primary Health Care, Delivery of Health Care, Integrated, Ambulatory Care, Community Health Services, Pharmacists, Community Pharmacy Services, Professional Practice, Canada

Abstract

Canada’s universal public health care system provides physician, diagnostic, and hospital services at no cost to all Canadians, accounting for approximately 70% of the 264 billion CAD spent in health expenditure yearly. Pharmacy-related services, including prescription drugs, however, are not universally publicly insured. Although this system underpins the Canadian identity, primary health care reform has long been desired by Canadians wanting better access to high quality, effective, patient-centred, and safe primary care services. A nationally coordinated approach to remodel the primary health care system was incited at the turn of the 21st century yet, twenty years later, evidence of widespread meaningful improvement remains underwhelming. As a provincial/territorial responsibility, the organization and provision of primary care remains discordant across the country. Canadian pharmacists are, now more than ever, poised and primed to provide care integrated with the rest of the primary health care system. However, the self-regulation of the profession of pharmacy is also a provincial/territorial mandate, making progress toward integration of pharmacists into the primary care system incongruent across jurisdictions. Among 11,000 pharmacies, Canada’s 28,000 community pharmacists possess varying authority to prescribe, administer, and monitor drug therapies as an extension to their traditional dispensing role. Expanded professional services offered at most community pharmacies include medication reviews, minor/common ailment management, pharmacist prescribing for existing prescriptions, smoking cessation counselling, and administration of injectable drugs and vaccinations. Barriers to widely offering these services include uncertainties around remuneration, perceived skepticism from other providers about pharmacists’ skills, and slow digital modernization including limited access by pharmacists to patient health records held by other professionals. Each province/territory enables pharmacists to offer these services under specific legislation, practice standards, and remuneration models unique to their jurisdiction. There is also a small, but growing, number of pharmacists across the country working within interdisciplinary primary care teams. To achieve meaningful, consistent, and seamless integration into the interdisciplinary model of Canadian primary health care reform, pharmacy advocacy groups across the country must coordinate and collaborate on a harmonized vision for innovation in primary care integration, and move toward implementing that vision with ongoing collaboration on primary health care initiatives, strategic plans, and policies. Canadians deserve to receive timely, equitable, and safe interdisciplinary care within a coordinated primary health care system, including from their pharmacy team.

Abstract 5567 | pdf Downloads 1401

References

1. Statistics Canada. Canadian Community Health Survey - Annual Component (CCHS). https://www23.statcan.gc.ca/imdb/p2SV.pl?Function=getSurvey&SDDS=3226 (accessed May 18, 2020).
2. Canadian Institute for Health Information. National Health Expenditure Trends, 1975 to 2019. https://www.cihi.ca/en/national-health-expenditure-trends-1975-to-2019 (accessed May 18, 2020).
3. Canada’s Health Care System. https://www.canada.ca/en/health-canada/services/health-care-system/reports-publications/health-care-system/canada.html (accessed May 18, 2020).
4. Canada Health Act 1985. https://laws-lois.justice.gc.ca/eng/acts/c-6/page-1.html (accessed May 18, 2020).
5. Boozary A, Laupacis A. The mirage of universality: Canada's failure to act on social policy and health care. CMAJ. 2020;192(5):E105-E106. https://doi.org/10.1503/cmaj.200085
6. Brandt J, Shearer B, Morgan SG. Prescription drug coverage in Canada: a review of the economic, policy and political considerations for universal pharmacare. J Pharm Policy Pract. 2018;11:28. https://doi.org/10.1186/s40545-018-0154-x
7. Government of Canada. Indigenous Health. https://www.sac-isc.gc.ca/eng/1569861171996/1569861324236 (accessed Aug 16, 2020).
8. Canadian Life and Health Insurance Association. Canadian Life & Health Insurance Facts. https://www.clhia.ca/web/CLHIA_LP4W_LND_Webstation.nsf/resources/Factbook_2/$file/2019+Factbook+English.pdf (accessed May 26, 2020).
9. Health Council of Canada. Primary Health Care: A Background Paper to Accompany Health Care Renewal in Canada: Accelerating Change. https://healthcouncilcanada.ca/files/2.44-BkgrdPrimaryCareENG.pdf (accessed Jun 10, 2020).
10. Aggarwal M, Hutchison BG, Canadian Foundation for Healthcare Improvement. Toward a Primary Care Strategy for Canada. Canadian Foundation for Healthcare Improvement. https://www.deslibris.ca/ID/235686 (accessed Jun 10, 2020).
11. Peckham A, Ho J, Marchildon G. Policy innovations in primary care across Canada. https://ihpme.utoronto.ca/wp-content/uploads/2018/04/NAO-Rapid-Review-1_EN.pdf (accessed May 18, 2020).
12. Mable AL, Marriott JF. Sharing the Learning: The Health Transition Fund. Synthesis Series - Primary Health Care. Health Canada. https://www.hhr-rhs.ca/index.php?option=com_mtree&task=viewlink&link_id=5266&Itemid=109&lang=en (accessed May 18, 2020).
13. Primary Health Care Transition Fund (Canada), Canada, Health Canada. Primary Health Care Transition Fund: Summary of Initiatives. Health Canada. https://www.canada.ca/en/health-canada/services/health-care-system/reports-publications/primary-health-care/summary-initiatives-final-edition-march-2007.html (accessed May 18, 2020).
14. Hutchison B, Levesque JF, Strumpf E, Coyle N. Primary health care in Canada: systems in motion. Milbank Q. 2011;89(2):256-288. https://doi.org/10.1111/j.1468-0009.2011.00628.x
15. Health Council of Canada. Health Care Renewal in Canada: Accelerating Change. https://healthcouncilcanada.ca/files/2.48-Accelerating_Change_HCC_2005.pdf (accessed May 25, 2020).
16. Health Council of Canada. Better Health, Better Care, Better Value for All: Refocusing Health Care Reform in Canada. https://healthcouncilcanada.ca/773/ (accessed Jun 10, 2020).
17. Health Council of Canada. The Health Council of Canada’s departing message in support of future health care reform. https://healthcouncilcanada.ca/834/ (accessed May 26, 2020).
18. Canadian Institute for Health Information. Primary Health Care in Canada: A Chartbook of Selected Indicator Results, 2016. https://www.deslibris.ca/ID/10090273 (accessed Aug 16, 2020).
19. College of Family Physicians of Canada. The Patient’s Medical Home Provincial Report Card - February 2019. https://patientsmedicalhome.ca/news/the-patients-medical-home-provincial-report-card-2019/ (accessed Aug 16, 2020).
20. Feeley D. The Triple Aim or the Quadruple Aim? Four Points to Help Set Your Strategy. Line of Sight. http://www.ihi.org/communities/blogs/the-triple-aim-or-the-quadruple-aim-four-points-to-help-set-your-strategy (accessed Sep 17, 2020).
21. Public Health Agency of Canada. How Healthy Are Canadians?: A Trend Analysis of the Health of Canadians from a Healthy Living and Chronic Disease Perspective. http://epe.lac-bac.gc.ca/100/201/301/weekly_acquisitions_list-ef/2017/17-14/publications.gc.ca/collections/collection_2017/aspc-phac/HP40-167-2016-eng.pdf (accessed Aug 16, 2020).
22. Canadian Institute for Health Information. Prescribed Drug Spending in Canada, 2019: A Focus on Public Drug Programs. https://www.cihi.ca/sites/default/files/document/pdex-report-2019-en-web.pdf (accessed Sep 10, 2020).
23. Canadian Institute for Health Information. Health System Resources for Mental Health and Addictions Care in Canada. https://www.cihi.ca/sites/default/files/document/mental-health-chartbook-report-2019-en-web.pdf (accessed Aug 16, 2020).
24. Colledge M. Press Release: If Premier for a Day, Canadians Would Ask the Federal Government to Help Them Improve Access to Health Care Services. https://www.ipsos.com/sites/default/files/ct/news/documents/2019-07/accesstohealthcare-factum-2019-07-08-v1.pdf (accessed Jun 10, 2020).
25. Buchman S. Open Letter to Canada’s Premiers. https://www.cma.ca/open-letter-canadas-premiers (accessed May 25, 2020).
26. College of Family Physicians of Canada, Canadian Pharmacists Association. Integration of Pharmacists Into Interprofessional Teams. https://portal.cfpc.ca/ResourcesDocs/uploadedFiles/Health_Policy/IPC-2019-Pharmacist-Integration.pdf (accessed Jun 10, 2020).
27. Canadian Pharmacists Association. CPhA Strategic Plan 2017-2020. https://www.pharmacists.ca/cpha-ca/assets/File/about-cpha/StratPlanEN.pdf (accessed Jul 2, 2020).
28. National Association of Pharmacy Regulatory Authorities. National Statistics. https://napra.ca/national-statistics (accessed Jul 2, 2020).
29. Labrie Y, Institut économique de Montréal. Pharmacies in Canada: Accessible Private Health Care Services. In: The Other Health Care System: Four Areas Where the Private Sector Answers Patients’ Needs. https://www.iedm.org/sites/default/files/pub_files/cahier0115_en.pdf (accessed Jul 2, 2020).
30. IQVIA. Retail pharmacies by outlet type, Canada, 2013-2019. https://www.iqvia.com/-/media/iqvia/pdfs/canada/2019-trends/retailpharmaciesoutlet_en_19.pdf?la=en&hash=993284F83D94374AA13D3E7EA3F7033E (accessed Jul 2, 2020).
31. IBIS World. Pharmacies & Drug Stores in Canada - Market Research Report. https://www.ibisworld.com/canada/market-research-reports/pharmacies-drug-stores-industry/ (accessed Sep 19, 2020).
32. Canadian Pharmacists Association. A Review of Pharmacy Services in Canada and the Health and Economic Evidence. https://www.pharmacists.ca/cpha-ca/assets/File/cpha-on-the-issues/Pharmacy%20Services%20Report%201.pdf (accessed Jul 18, 2020).
33. Association of Faculties of Pharmacy of Canada. Health Workforce Database. https://www.cihi.ca/en/pharmacists (accessed Jul 2, 2020).
34. Canadian Institute for Health Information. Pharmacists in Canada, 2019 - Data Tables. https://www.cihi.ca/en/pharmacists-in-canada-2019 (accessed Aug 16, 2020).
35. Management Committee. Moving Forward: Pharmacy Human Resources for the Future. Final Report. https://www.hhr-rhs.ca/index.php?option=com_mtree&task=att_download&link_id=4506&cf_id=68&lang=en (accessed Jul 18, 2020).
36. Coletto D. Pharmacists in Canada: A national survey of Canadians on their perceptions and attitudes towards pharmacists. https://www.pharmacists.ca/cpha-ca/assets/File/pharmacy-in-canada/CPhA_NationalReport_BRIEFING.pdf (accessed Jul 2, 2020).
37. Tsuyuki RT, Beahm NP, Okada H, Al Hamarneh YN. Pharmacists as accessible primary health care providers: Review of the evidence. Can Pharm J Rev Pharm Can. 2018;151(1):4-5. doi:10.1177/1715163517745517
38. Yuksel N, Eberhart G, Bungard TJ. Prescribing by pharmacists in Alberta. Am J Health Syst Pharm. 2008;65(22):2126-2132. doi:10.2146/ajhp080247
39. Canadian Foundation for Pharmacy. Claims trends paint compelling picture for services. https://www.cfpnet.ca/en/news/details/id/293 (accessed Aug 16, 2020).
40. McCarthy LM, Luke MJ. Professional pharmacy services. In: Encyclopedia of Pharmacy Practice and Clinical Pharmacy. Cambridge, MS: Academic press; 2019. ISBN: 9780128127353.
41. Rose O, Mennemann H, John C, Lautenschläger M, Mertens-Keller D, Richling K, Waltering I, Hamacher S, Felsch M, Herich L, Czarnecki K, Schaffert C, Jaehde U, Köberlein-Neu J. Priority Setting and Influential Factors on Acceptance of Pharmaceutical Recommendations in Collaborative Medication Reviews in an Ambulatory Care Setting - Analysis of a Cluster Randomized Controlled Trial (WestGem-Study). PLoS One. 2016;11(6):e0156304. https://doi.org/10.1371/journal.pone.0156304
42. Pammett R, Jorgenson D. Eligibility requirements for community pharmacy medication review services in Canada. Can Pharm J (Ott). 2014;147(1):20-24. https://doi.org/10.1177/1715163513514006
43. Ontario Pharmacists Association. MedsCheck Program. https://www.opatoday.com/professional/resources/for-pharmacists/programs/medscheck (accessed Jul 21, 2020).
44. Pechlivanoglou P, Abrahamyan L, MacKeigan L, Consiglio GP, Dolovich L, Li P, Cadarette SM, Rac VE, Shin J, Krahn M. Factors affecting the delivery of community pharmacist-led medication reviews: evidence from the MedsCheck annual service in Ontario. BMC Health Serv Res. 2016;16(1):666. https://doi.org/10.1186/s12913-016-1888-2
45. Shakeri A, Dolovich L, MacCallum L, Gamble JM, Zhou L, Cadarette SM. Impact of the 2016 Policy Change on the Delivery of MedsCheck Services in Ontario: An Interrupted Time-Series Analysis. Pharmacy (Basel). 2019;7(3):115. https://doi.org/10.3390/pharmacy703015
46. Kosar L, Hu N, Lix LM, Shevchuk Y, Teare GF, Champagne A, Blackburn DF. Uptake of the Medication Assessment Program in Saskatchewan: Tracking claims during the first year. Can Pharm J (Ott). 2017;151(1):24-28. https://doi.org/10.1177/1715163517744228
47. Lapointe-Shaw L, Bell CM, Austin PC, Abrahamyan L, Ivers NM, Li P, Pechlivanoglou P, Redelmeier DA, Dolovich L. Community pharmacy medication review, death and re-admission after hospital discharge: a propensity score-matched cohort study. BMJ Qual Saf. 2020;29(1):41-51. https://doi.org/10.1136/bmjqs-2019-009545
48. Gauvin F, Lavis J, McCarthy L. Evidence Brief: Exploring Models for Pharmacist Prescribing in Primary and Community Care Settings in Ontario. https://www.mcmasterforum.org/docs/default-source/Product-Documents/evidence-briefs/models-for-pharmacist-prescribing-in-ontario-eb.pdf (accessed Jul 18, 2020).
49. Nakhla N, Killeen R, Butt K. Pharmacist-led Smoking CessationCare in Canada: Current Status & Strategies for Expansion. https://uwaterloo.ca/pharmacy/sites/ca.pharmacy/files/uploads/files/whitepaper_final_nov_28_2019.pdf (accessed Jul 21, 2020).
50. Wong L, Burden AM, Liu YY, Tadrous M, Pojskic N, Dolovich L, Calzavara A, Cadarette SM. Initial uptake of the Ontario Pharmacy Smoking Cessation Program: Descriptive analysis over 2 years. Can Pharm J (Ott). 2015;148(1):29-40. https://doi.org/10.1177/1715163514562038
51. Law MR, Ma T, Fisher J, Sketris IS. Independent pharmacist prescribing in Canada. Can Pharm J (Ott). 2012;145(1):17-23.e1. https://doi.org/10.3821/1913-701x-145.1.17
52. Health Canada. Subsection 56(1) class exemption for patients, practitioners and pharmacists prescribing and providing controlled substances in Canada during the coronavirus pandemic. https://www.canada.ca/en/health-canada/services/health-concerns/controlled-substances-precursor-chemicals/policy-regulations/policy-documents/section-56-1-class-exemption-patients-pharmacists-practitioners-controlled-substances-covid-19-pandemic.html (accessed Aug 29, 2020).
53. Canadian Foundation for Pharmacy. Provincial changes in provision of services and dispensing practices related to COVID-19. https://www.cfpnet.ca/bank/document_en/150-2020-cfp-covid-19-chart-july-31.pdf (accessed Aug 29, 2020).
54. Canadian Foundation for Pharmacy. Professional service fees and claims data for government-sponsored pharmacist services, by province. https://cfpnet.ca/bank/document_en/129-2018-provincial-chart.pdf (accessed Sep 23, 2020).
55. Nova Scotia Department of Health and Wellness. Pharmacy Service Agreement. October 1, 2019. https://novascotia.ca/dhw/pharmacare/documents/Pharmacy-Service-Agreement.pdfn (accessed Sep 30, 2020).
56. Gagnon-Arpin I, Dobrescu A, Sutherland G, Stonebridge C, Dinh T. The Value of Expanded Pharmacy Services in Canada. The Conference Board of Canada. https://www.conferenceboard.ca/e-library/abstract.aspx?did=8721 (accessed Jul 23, 2020).
57. Government of Canada. Vaccine uptake in Canadian Adults 2019. https://www.canada.ca/en/public-health/services/publications/healthy-living/2018-2019-influenza-flu-vaccine-coverage-survey-results.html (accessed Jul 23, 2020).
58. Buchan SA, Rosella LC, Finkelstein M, Juurlink D, Isenor J, Marra F, Patel A, Russell ML, Quach S, Waite N, Kwong JC; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Program Delivery and Evaluation Group. Impact of pharmacist administration of influenza vaccines on uptake in Canada. CMAJ. 2017;189(4):E146-E152. https://doi.org/10.1503/cmaj.151027
59. O'Reilly DJ, Blackhouse G, Burns S, Bowen JM, Burke N, Mehltretter J, Waite NM, Houle SK. Economic analysis of pharmacist-administered influenza vaccines in Ontario, Canada. Clinicoecon Outcomes Res. 2018;10:655-663. https://doi.org/10.2147/ceor.s167500
60. Special Advisory Committee on the Epidemic of Opioid Overdoses. Opioid-Related Harms in Canada. Public Health Agency of Canada. https://health-infobase.canada.ca/substance-related-harms/opioids (accessed Aug 29, 2020).
61. de Villa E. Toronto Overdose Action Plan: Status Report 2020. https://www.toronto.ca/legdocs/mmis/2020/hl/bgrd/backgroundfile-147549.pdf (accessed Sep 19, 2020).
62. Canadian Institute for Health Information. Opioid Prescribing in Canada: How Are Practices Changing?. https://www.cihi.ca/sites/default/files/document/opioid-prescribing-canada-trends-en-web.pdf (accessed Aug 29, 2020).
63. Belzak L, Halverson J. The opioid crisis in Canada: a national perspective. La crise des opioïdes au Canada : une perspective nationale. Health Promot Chronic Dis Prev Can. 2018;38(6):224-233. https://doi.org/10.24095/hpcdp.38.6.02
64. towardtheheart. Take Home Naloxone in British Columbia Infographic. https://towardtheheart.com/thn-in-bc-infograph (accessed Sep 19, 2020).
65. Jorgenson D, Dalton D, Farrell B, Tsuyuki RT, Dolovich L. Guidelines for pharmacists integrating into primary care teams. Can Pharm J (Ott). 2013;146(6):342-352. https://doi.org/10.1177/1715163513504528
66. Jorgenson D, Laubscher T, Lyons B, Palmer R. Integrating pharmacists into primary care teams: barriers and facilitators. Int J Pharm Pract. 2014;22(4):292-299. https://doi.org/10.1111/ijpp.12080
67. Samir Abdin M, Grenier-Gosselin L, Guénette L. Impact of pharmacists' interventions on the pharmacotherapy of patients with complex needs monitored in multidisciplinary primary care teams. Int J Pharm Pract. 2020;28(1):75-83. https://doi.org/10.1111/ijpp.12577
68. Gillespie U, Dolovich L, Dahrouge S. Activities performed by pharmacists integrated in family health teams: Results from a web-based survey. Can Pharm J (Ott). 2017;150(6):407-416. https://doi.org/10.1177/1715163517733998
69. Smith MA. Primary Care Teams and Pharmacist Staffing Ratios: Is There a Magic Number?. Ann Pharmacother. 2018;52(3):290-294. https://doi.org/10.1177/1060028017735119
70. NHS England. Clinical Pharmacists in General Practice Phase 2 Guidance for applicants. https://www.england.nhs.uk/wp-content/uploads/2018/10/clinical-pharmacists-in-gp-phase-2-guidance-applicants.pdf (accessed Aug 29, 2020).
71. Rosser WW, Colwill JM, Kasperski J, Wilson L. Progress of Ontario's Family Health Team model: a patient-centered medical home. Ann Fam Med. 2011;9(2):165-171. https://doi.org/10.1370/afm.1228
72. Gobis B, Reardon J, Yuen J, et al. A White Paper on Team-Based Primary Health Care in British Columbia – Context and Opportunities for Pharmacists. https://pharmsci.ubc.ca/sites/pharmsci.ubc.ca/files/A%20White%20Paper%20on%20Team-Based%20Primary%20Health%20Care%20in%20British%20Columbia%20%E2%80%93%20Context%20and%20Opportunities%20for%20Pharmacists_UBCPS_2020.pdf (accessed Aug 29, 2020).
73. Losinski V. Pharmacist Services Framework Within Saskatchewan Primary Health Care. https://www.saskpharm.ca/document/5820/Pharmacist_Servs_Frmwk_20130628.pdf (accessed Aug 29, 2020).
74. Health Council of Canada. Progress Report 2011: Health Care Renewal in Canada. https://healthcouncilcanada.ca/165/ (accessed May 23, 2020).
75. Canadian Institutes of Health Research. Community-Based Primary Healthcare. http://www.cihr-irsc.gc.ca/e/43626.html (accessed Jul 2, 2020).
76. College of Family Physicians of Canada. Best Advice Guide: Patient’s Medical Neighbourhood. https://patientsmedicalhome.ca/resources/best-advice-guides/the-patients-medical-neighbourhood/ (accessed Jul 2, 2020).
77. Jorgenson D, Lamb D, MacKinnon NJ. Practice Change Challenges and Priorities: A National Survey of Practising Pharmacists. Can Pharm J Rev Pharm Can. 2011;144(3):125-131. https://doi.org/10.3821/1913-701X-144.3.125
78. Zhou M, Desborough J, Parkinson A, Douglas K, McDonald D, Boom K. Barriers to pharmacist prescribing: a scoping review comparing the UK, New Zealand, Canadian and Australian experiences. Int J Pharm Pract. 2019;27(6):479-489. https://doi.org/10.1111/ijpp.12557
79. Austin Z, Gregory P. Learning Needs of Pharmacists for an Evolving Scope of Practice. Pharmacy (Basel). 2019;7(4):140. https://doi.org/10.3390/pharmacy7040140
80. Gregory PAM, Teixeira B, Austin Z. What does it take to change practice? Perspectives of pharmacists in Ontario. Can Pharm J (Ott). 2017;151(1):43-50. https://doi.org/10.1177/1715163517742677
81. Dinh T, Stonebridge C. Getting the Most out of Community Pharmacy: Recommendations for Action. https://www.conferenceboard.ca/e-library/abstract.aspx?did=8796 (accessed Jul 23, 2020).
82. MacCallum L, Mathers A, Kellar J, Rousse-Grossman J, Moore J, Lewis GF, Dolovich L. Pharmacists report lack of reinforcement and the work environment as the biggest barriers to routine monitoring and follow-up for people with diabetes: A survey of community pharmacists. Res Social Adm Pharm. 2020;S1551-7411(19)31114-3. https://doi.org/10.1016/j.sapharm.2020.04.004
83. Emberley P. Canadian Pharmacists Scope 20/20: A vision for harmonized pharmacists' scope in Canada. Can Pharm J (Ott). 2018;151(6):419-420. https://doi.org/10.1177/1715163518804148
84. Canadian Pharmacists Association. Canadian Pharmacists’ Harmonized Scope. https://www.pharmacists.ca/pharmacy-in-canada/canadian-pharmacists-harmonized-scope/#resources (accessed Jul 2, 2020).
85. Tsuyuki RT, Al Hamarneh YN, Jones CA, Hemmelgarn BR. The Effectiveness of Pharmacist Interventions on Cardiovascular Risk: The Multicenter Randomized Controlled RxEACH Trial. J Am Coll Cardiol. 2016;67(24):2846-2854. https://doi.org/10.1016/j.jacc.2016.03.528
86. Tsuyuki RT, Rosenthal M, Pearson GJ. A randomized trial of a community-based approach to dyslipidemia management: Pharmacist prescribing to achieve cholesterol targets (RxACT Study). Can Pharm J (Ott). 2016;149(5):283-292. https://doi.org/10.1177/1715163516662291